Long-lasting antibody persistence was comparable in older (65+) and younger adultsLong-term antibody persistence is a key competitive advantage for a vaccine targeting unpredictable outbreak diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback